Fact sheet: Manulife Healthcare

Fund information

Fund name
Manulife Healthcare AA
Fund company manager
Manulife Global Fund
Fund type
SIB
Fund manager
Manulife Asset Management (US) LLC
since 27/06/2008
Fund objective
The sub-fund aims to provide medium to long term capital growth for those who hold a long term investment view and who are prepared to accept significant fluctuations in the value of their investments in order to achieve long term returns. It is intended that the investments will be made on a diversified basis. The underlying investment portfolio will mainly consist of equity-related investments and equities of companies in healthcare and related industries globally and which are listed on any stock exchange. The sub-fund may invest in companies which derive a significant portion of their earnings from medical and pharmaceutical products and services. The remaining assets of the sub-fund may include bonds, deposits and other investments.
Benchmark
MSCI World Health Care Index
Investment style
Growth
Investment method
Shares

Quick stats

1 Year return

1.49 %

1 Year rank in sector

19/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 289.5 m

FE Risk score

126

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    64.68%
  • UK
    8.74%
  • Switzerland
    7.22%
  • Germany
    5.48%
  • Ireland
    5.47%
  • Pharmaceuticals
    48.64%
  • Biotechnology/Medical
    26.22%
  • Healthcare & Medical Products
    15.56%
  • Health Care
    7.86%
  • Food & Drug Retailers
    1.5%
  • US Equities
    64.68%
  • UK Equities
    8.74%
  • Swiss Equities
    7.22%
  • German Equities
    5.48%
  • Irish Equities
    5.47%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-1.81 %5.26 %1.49 %15.59 %70.81 %
Sector-2.14 %3.95 %6.57 %24.27 %99.62 %
Rank within sector16 / 3013 / 2919 / 2917 / 2620 / 23
Quartile th3 rd2 nd3 rd3 rd4 th

Calendar performance

YTD-20172016201520142013
Fund10.7 %-7.31 %1.3 %19.2 %32.27 %
Sector12.56 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector19 / 299 / 2924 / 2723 / 2415 / 23
Quartile th3 rd2 nd4 th4 th3 rd

Risk statistics

Alpha-0.76
Beta0.72
Sharpe0.14
Volatility12.13
Tracking error6.74
Information ratio-0.42
R-Squared0.84

Price movement

52 week high2.0108
52 week low1.6851
Current bid price0
Current offer price0
Current mid price1.9416

Holdings by region

  • 64.68% USA
  • 8.74% UK
  • 7.22% Switzerland
  • 5.48% Germany
  • 5.47% Ireland
  • 3.83% Denmark
  • 2.7% France
  • 1.27% Japan
  • 0.39% Others
  • 0.22% Money Market

Holdings by sector

  • 48.64% Pharmaceuticals
  • 26.22% Biotechnology/Medical
  • 15.56% Healthcare & Medical Products
  • 7.86% Health Care
  • 1.5% Food & Drug Retailers
  • 0.22% Cash & Cash Equivalents

Holdings by asset type

  • 64.68% US Equities
  • 8.74% UK Equities
  • 7.22% Swiss Equities
  • 5.48% German Equities
  • 5.47% Irish Equities
  • 3.83% Danish Equities
  • 2.7% French Equities
  • 1.27% Japanese Equities
  • 0.39% International Equities
  • 0.22% Money Market

Individual holdings

  • 6.76% JOHNSON & JOHNSON
  • 4.74% BIOGEN INC
  • 4.57% MERCK & CO INC(NEW)
  • 4.36% ALLERGAN PLC
  • 4.35% ASTRAZENECA PLC
  • 3.95% ROCHE HLDG AG
  • 3.83% NOVO-NORDISK AS
  • 3.71% PFIZER INC
  • 3.64% AMGEN INC
  • 3.64% GILEAD SCIENCES INC